Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Epidemiology 2: Epidemiology of Breast and Prostate Cancer

Risk factors associated with estrogen and progesterone receptor-defined breast tumors

M. Althuis, M. Garcia-Closas, J. Lissowska, N. Szeszenia-Dabrowska, A. Bardin-Mikolajczak, M. Sklodowska, B. Peplonska, R. Kordek, S. Lukaszek, W. Oszewski, L. Brinton and M. Sherman
M. Althuis
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Garcia-Closas
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Lissowska
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Szeszenia-Dabrowska
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Bardin-Mikolajczak
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Sklodowska
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Peplonska
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Kordek
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Lukaszek
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Oszewski
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Brinton
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Sherman
NCI, Rockville, MD, Cancer Center & M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland, Nofer Institute of Occupational Medicine, Lodz, Poland, Medical University of Lodz, Lodz, Poland, Polish Mother Health Center, Lodz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2004
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 45, 2004

Abstract

1082

Accumulating evidence suggests that the etiology of hormone receptor-defined breast cancers may be heterogeneous, with hormonal factors more strongly associated with hormone receptor-positive than receptor-negative cancer risk (Althuis et al., Ann Epidemiol. 2003 Sept: 13(8): 559). This study compares risk factor profiles for breast cancers stratified by estrogen (ER) and progesterone receptor status (PR) among pre and postmenopausal women from a population-based case-control study in Poland. Incident breast cancer cases, aged 25-74 years diagnosed during 2000-2003, were identified by participating hospitals (>90% of cases) and cancer registries. Controls were randomly selected from population lists and frequency matched to cases within 5 year age groups. Seventy-nine percent of eligible cases and 68% of eligible controls agreed to participate in the study and completed a detailed questionnaire. This report includes 1,955 controls and 1,265 breast cancer cases, representing all cases available at the time of analysis who were not treated prior to surgery (89% of cancers) and with information on ER and PR status (79% of invasive and 29% of in situ cancers) determined by either immunohistochemistry (>95%) or biochemical methods at the treating hospital. Multivariate polytomous logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for ER+/PR+ and ER-/PR- breast cancer risk. Among 243 premenopausal women, increased risk of ER+/PR+ but not ER-/PR- tumors was associated with a later age at first birth (30+ vs. <20 years: ORER+/PR+=3.2 (CI, 1.0-9.5); ORER-/PR-=0.8 (0.2-2.3); P-value for interaction = 0.03), nulliparity (vs. parous: ORER+/PR+=2.9 (1.0-5.2); ORER-/PR-=0.9 (0.2-2.1); P = 0.11), and a lower body mass index (lowest vs. highest quartile: ORER+/PR+=3.1 (1.4-5.0); ORER-/PR-=1.3 (0.6-2.5); P = 0.05). Among 717 postmenopausal women, ER+/PR+ but not ER-/PR- tumors were associated with increasing body mass index (highest vs. lowest quartile: ORER+/PR+=1.3 (1.0-1.8); ORER-/PR-=0.8 (0.5-1.1); P = 0.02). Risks associated with age at menarche, age at menopause, alcohol consumption, oral contraceptive use, family history, and cigarette smoking did not differ by receptor status for either pre or postmenopausal women. Expansion of this work to the remaining breast cancer cases (∼880) and improvement of measures of ER and PR expression using quantitative immunostaining methods should further clarify these relationships and may help elucidate relationships obscured by currently employed techniques.

  • American Association for Cancer Research
Previous
Back to top
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Risk factors associated with estrogen and progesterone receptor-defined breast tumors
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Risk factors associated with estrogen and progesterone receptor-defined breast tumors
M. Althuis, M. Garcia-Closas, J. Lissowska, N. Szeszenia-Dabrowska, A. Bardin-Mikolajczak, M. Sklodowska, B. Peplonska, R. Kordek, S. Lukaszek, W. Oszewski, L. Brinton and M. Sherman
Cancer Res April 1 2004 (64) (7 Supplement) 246;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk factors associated with estrogen and progesterone receptor-defined breast tumors
M. Althuis, M. Garcia-Closas, J. Lissowska, N. Szeszenia-Dabrowska, A. Bardin-Mikolajczak, M. Sklodowska, B. Peplonska, R. Kordek, S. Lukaszek, W. Oszewski, L. Brinton and M. Sherman
Cancer Res April 1 2004 (64) (7 Supplement) 246;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Finger pattern and prostate cancer risk: A case-control study using BPH and community-based population as controls
  • Dietary intake of conjugated linoleic acids and risk of pre- and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study)
  • Environmental variables and family history of breast cancer
Show more Epidemiology 2: Epidemiology of Breast and Prostate Cancer
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement